NASDAQ · Health care

Nuvectis Pharma, Inc. (NVCT)

It posted a net loss of $27.8M. At June 30, 2026 it held $22.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 4, 2026.

Price

$20.22

-6.52% on the day · September 25, 2026

52-week range $5.55 to $29.28

Market cap

$658.8M

What Nuvectis Pharma, Inc. does

Nuvectis Pharma, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NVCT.

Revenue and profit by year

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	n/a	-$27.6M	-$26.4M	-$1.32	n/a
2024	n/a	-$19.8M	-$19M	-$1.11	n/a
2023	n/a	-$22.9M	-$22.3M	-$1.43	n/a
2022	n/a	-$19.2M	-$19.1M	-$1.51	n/a
2022	n/a	-$12.9M	-$12.9M	-$3.02	n/a

Next report expected around November 3, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 4, 2025. Not a date the company has announced. See the report calendar

Latest SEC filings

What Nuvectis Pharma, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

August 21, 2026
Shelf registration to sell securities S-3
August 21, 2026
Other event 8-K
August 6, 2026
Passive stake (5% or more) SCHEDULE 13G
August 4, 2026
Quarterly report 10-Q · period to June 30, 2026
August 4, 2026
Quarterly results 8-K
June 30, 2026
Material agreement 8-K
June 30, 2026
Securities offering prospectus 424B5
June 29, 2026
Securities offering prospectus 424B5
June 29, 2026
Other event 8-K
June 23, 2026
Material agreement 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 5, 2026. Insider transactions on SEC

Insider trades

What the people running Nuvectis Pharma, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)

last 90 days

Sold

last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about NVCT

What does Nuvectis Pharma, Inc. do?

Nuvectis Pharma, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NVCT.

Is Nuvectis Pharma, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $27.8M.

When did Nuvectis Pharma, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 4, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the shelf registration to sell securities from August 21, 2026.

Similar companies

Compare NVCT with

Compare NVCT with any company

Follow NVCT

Get an email when Nuvectis Pharma, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow NVCT: get an email when it files

Where the numbers come from

Financial figures are the values Nuvectis Pharma, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.